Published: April 2017 (Amended 2020)
Read Full-Text Guideline
This multisociety guideline addresses four topics related to the treatment of muscle-invasive bladder cancer that has not metastasized. 1) initial patient evaluation and counseling; 2) recommendations on treatment therapies (neoadjuvant chemotherapy, radical cystectomy, pelvic lymphadectomy and bladder preserving approaches). 3) patient surveillance, follow-up and survivorship; and 4) the role of variant histology for management of urothelial carcinoma.
Developed in collaboration with:
Muscle Invasive Bladder Cancer Algorithm (Amended 2020)